Sonus Pharmaceuticals About
Sonus Pharmaceuticals reuters ---Sonus Pharmaceuticals, Inc.
is a drug reformulation company focused
on the optimization of therapeutic drugs
to treat cancer and other serious diseases.
The Company is developing a number of
potential product candidates utilizing
its TOCOSOL drug delivery technology.
The TOCOSOL technology platform, designed
to address the formulation challenges
of therapeutic drugs, uses vitamin E oil
(tocopherol) and tocopherol derivatives
to solubilize and stabilize drugs for
formulation enhancement, and is particularly
suited to injectable drugs that are poorly
soluble in water. The Company's lead product,
TOCOSOL Paclitaxel, is a formulation of
paclitaxel, a prescribed anti-cancer drugs.
TOCOSOL Paclitaxel is a ready-to-use injectable
paclitaxel emulsion. MORE
ABOUT THE TECHNOLOGY --
The technology uses vitamin E and vitamin
E derivatives to solubilize, stabilize
and formulate drugs with the goal of enhancing
their delivery, safety and efficacy.